Tag Archives: Optum

Celltrion Healthcare Contracts with CarePartners Pharmacy for Yuflyma

Celltrion Healthcare recently signed an agreement with Libertyville, IL-based CarePartners Pharmacy to sell its Humira biosimilar Yuflyma in the U.S. market

FTC Expands Study of PBM Drug Pricing

The FTC is expanding its ongoing study on pharmacy benefit managers (PBMs) and their impact on the accessibility and affordability of prescription drugs

Leading Stakeholders Continue to Acquire Primary Care Practices

Combined with a number of recent acquisitions and ongoing consolidation by market participants, we view the primary care market undergoing a major transformation over the next few years.

Specialty Pharmacy News Roundup: April 2023

The latest in specialty pharmacy news and research. Stay up to date on companies and industry trends at the forefront of the specialty pharmacy industry. 

Primary Care Providers: Evolving in 2023-2024

AMI’s new report, Primary Care Providers: Evolving in 2023-2024 provides a background of the primary care market and profiles the companies that will be leading the market in 2023 and beyond

QOL Medical Selects Optum Frontier Therapies as New Partner for Sucraid®

QOL Medical Selects Optum Frontier Therapies as New Pharmacy Partner for Sucraid® to support CSID patients nationwide being treated with Sucraid® (sacrosidase) Oral Solution

Optum Specialty Fusion™ Launched To Streamline Care and Lower Costs

Optum Specialty Fusion™ was launched to streamline treatment decision-making for care providers, helping patients get on their therapies faster